Building Health-Data Interoperability: A Technical Blueprint for Better Care and Responsible AI

More health data does not automatically mean better AI. The real challenge is turning fragmented, inconsistent patient records into trusted, usable data.

Health systems generate clinical, laboratory, pharmacy, imaging, and insurance data at scale. But when this data is trapped in disconnected systems, clinicians cannot see the full patient history, patients repeat tests, and AI models are trained on incomplete or biased data.[1]

This article outlines a practical, technical architecture for health-data interoperability—with lessons from South Korea, the United States, the UAE, Denmark, Estonia, Singapore, Taiwan, and India.[1]

The real problem: unusable data

The issue is not a lack of data. It is that data is often:

• Stored in incompatible formats.
• Coded with different clinical terminologies.
• Fragmented across hospitals, labs, pharmacies, and insurers.
• Incomplete, outdated, or biased.
• Poorly governed for secondary use and AI training.[1]

The OECD emphasizes that health data should be findable, accessible, interoperable, reusable, and representative of the population.[1]

A useful distinction:

Use case	Goal	Example
Direct care	Treat an individual patient	Review medication history in an emergency
Secondary use	Research, quality improvement, policy	Evaluate treatment outcomes across regions
AI development	Build and validate predictive tools	Identify patients at high risk of readmission

Permission to use data for treatment does not automatically authorize its use for research, commercial development, or AI training. Governance must be purpose-specific.[1]

Interoperability: three levels

Interoperability is often oversimplified as “connecting systems.” In practice, it has three distinct levels.[1]

Level	Meaning	Example
Foundational	Secure transport of data	A hospital sends a lab result to another provider
Structural	Shared data model or message format	Systems can parse HL7 FHIR resources
Semantic	Shared clinical meaning	“Aspirin 75 mg daily” means the same thing everywhere

A common mistake is assuming that adopting FHIR automatically delivers semantic interoperability. It does not. FHIR is an exchange framework; clinical meaning must be supplied separately through terminologies and content models.[1]

FHIR, openEHR, and terminology

Two standards families dominate current practice, and they are complementary rather than competing.[1]

• HL7 FHIR structures the exchange of discrete data elements through standardized APIs. It is well suited to national exchange layers.
• openEHR provides an open, formal content model for clinical information, enabling reusable, vendor-neutral clinical templates.
• Terminologies such as SNOMED CT, LOINC, and RxNorm supply the clinical meaning that FHIR alone cannot.[1]

A national terminology and mapping service—covering licensing, maintenance, local-language mapping, and coder training—can represent a substantial recurring share of interoperability costs.[1]

Eight models, one lesson

No single country provides a complete blueprint. The most useful approach is to combine complementary strengths.[1]

Country	Core strength	Key lesson	Main limitation
South Korea	Federated research networks, OMOP	Analyze data where it is stored	Federated learning is not a privacy guarantee
United States	FHIR APIs, information-blocking rules	Standardized access unlocks innovation	Regulation does not guarantee data quality
UAE	Mandatory health-information exchange	Strong coordination accelerates adoption	Compliance needs funding and technical support
Denmark	Long-term linked registers	Data continuity enables population research	Requires mature institutions and universal ID
Estonia	Patient access, transparency, X-Road	Trust grows with visible access logs	Exchange layer is not a clinical database
Singapore	Secure AI platforms	AI must fit real clinical workflows	Deployment is not proof of impact
Taiwan	Insurance-linked clinical data	Insurance can connect care and surveillance	Claims data cannot replace clinical data
India	Federated, consent-based architecture	Building blocks can precede full exchange	Adoption is uneven, especially in private sector

Federated learning: useful, not magical

South Korea’s FeederNet demonstrates how hospitals can collaborate without surrendering control of raw patient records. The network uses the OMOP Common Data Model to standardize data for research, and a published feasibility study has demonstrated federated learning on a distributed OMOP research network in Korea.[1]

In a federated model, an algorithm is trained across multiple hospitals without moving all patient records into one central database. Institutions retain data locally and share only limited model updates or aggregated results.[1]

Important caveat: federated learning is not a privacy guarantee. Model updates can leak information through gradient-inversion and membership-inference attacks. It must be combined with access controls, encryption, audit trails, validation, and privacy-preserving techniques such as differential privacy or secure aggregation.[1]

A four-layer architecture

Developing countries should avoid copying a single national model. Instead, they should build a modular architecture that can evolve with capacity.[1]

+------------------------------------------------------+
| Layer 4: Applications and services                    |
| Patient portal, clinical decision support,            |
| public-health dashboards, provider tools              |
+------------------------------------------------------+
| Layer 3: Analytics and AI                             |
| Secure research environments, OMOP mapping,           |
| federated learning, model validation                  |
+------------------------------------------------------+
| Layer 2: Interoperability and exchange                |
| FHIR APIs, identity, consent, terminology,            |
| access audit logs                                     |
+------------------------------------------------------+
| Layer 1: Data sources                                 |
| Hospitals, clinics, labs, pharmacies, insurers,       |
| imaging, wearables                                    |
+------------------------------------------------------+
Governance, security, patient rights,
and independent oversight apply across all layers

Layer 1: Data sources

The foundation is reliable data capture at the point of care. Hospitals, labs, pharmacies, and insurers should use structured records, standardized terminology, and quality-control processes.[1]

Before anything else, patient identity must be solved. Duplicated and fragmented records for the same person silently corrupt every downstream use of the data. A national Master Patient Index (MPI)—covering matching, deduplication, and linkage—is a first-order priority, not an implementation detail.[1]

Priority actions:

• Define a minimum national dataset.
• Establish a national MPI and patient-matching strategy.
• Require structured data entry for high-value fields.
• Establish data-quality metrics.
• Create audit trails for data changes.
• Avoid treating PDFs and scans as “digital health data.”[1]

Layer 2: Interoperability

This layer enables secure exchange between systems. It should be built around open standards, particularly FHIR, while allowing local adaptation.[1]

Priority actions:

• Adopt FHIR-based APIs for priority data domains.
• Create a national terminology and mapping service.
• Require role-based access and tamper-evident access logs.
• Prevent vendor lock-in through open procurement rules.
• Establish a national identity and consent framework.[1]

Layer 3: Analytics and AI

This layer should separate operational analytics from AI development. Not every dataset needs to be centralized, and not every AI project needs a national platform.[1]

Priority actions:

• Create secure environments for secondary use.
• Map priority datasets to OMOP or a national common data model.
• Start with federated learning where data localization is essential.
• Require independent validation before deployment.
• Monitor models after launch for drift, bias, and safety.[1]

Layer 4: Applications

The final layer turns data into value for patients, clinicians, and policymakers.[1]

Priority actions:

• Build patient-facing access to records, test results, and access logs.
• Deploy clinical decision support for medication safety and duplicate testing.
• Give managers real-time dashboards for capacity and quality.
• Create early-warning systems for outbreaks and service disruptions.[1]

Start with three use cases

Countries should not begin with a nationwide AI moonshot. They should begin with problems that are frequent, measurable, and clinically meaningful.[1]

1. Reduce duplicate tests

Give clinicians secure access to prior lab results, imaging reports, and medication histories.[1]

Important caveat: evidence is mixed. Some studies show reduced duplicate imaging, while others find that exchange adoption alone does not reduce—and can transiently increase—testing rates. Reducing duplication requires workflow-level intervention, such as alerts and ordering-path changes, not just data access.[1]

Success measure: reduction in duplicate high-cost tests relative to baseline, controlling for overall testing volume.[1]

2. Prevent medication errors

Use shared medication records to identify duplicate prescriptions, dangerous interactions, and allergies.[1]

Success measure: reduction in preventable medication-related adverse events relative to baseline.[1]

3. Improve discharge summaries

Automatically compile relevant clinical information into a structured discharge summary, with clinician review before finalization.[1]

Success measure: reduction in incomplete or delayed discharge documentation relative to baseline.[1]

Governance is not optional

Technology alone cannot create trust. A national health-data system needs clear rules on who can access data, for what purpose, under which safeguards, and with what accountability.[1]

The OECD emphasizes privacy protection, secure access, interoperability, transparency, and effective governance. WHO identifies human autonomy, safety, transparency, responsibility, inclusiveness, and sustainability as core ethical principles for AI in health.[1]

Consent architecture

The single most consequential governance choice is the consent model:

• Opt-in maximizes autonomy but often produces low and skewed participation.
• Opt-out, with transparency and a right to object, achieves higher coverage; the European Health Data Space uses this model for most secondary use.
• Purpose-differentiated consent—opt-in for commercial/AI training, opt-out for public-interest research—is a practical middle path.[1]

This choice should be explicit, in primary legislation, with public deliberation—not an administrative default.[1]

Essential safeguards

• Legal basis and purpose limitation.
• Minimum necessary access.
• Consent and patient rights.
• Auditability.
• Retention and deletion.
• Cross-border and commercial-use safeguards.
• Independent oversight.
• AI-specific regulation.
• Human accountability.
• Breach notification and redress.[1]

Cybersecurity is a precondition

Cybersecurity is usually treated as an operational cost. It should be treated as a precondition for the entire agenda, because a single major incident can destroy public trust faster than a decade of investment can build it.[1]

In 2017, the WannaCry ransomware attack disrupted at least 81 of 236 NHS trusts in England, cancelled thousands of appointments and operations, and was judged preventable through basic patching.[1]

Priority actions:

• Treat the health-data network as critical national infrastructure.
• Mandate patching, network segmentation, backup/recovery, and incident drills.
• Establish a health-sector incident response capability.
• Include cybersecurity in the readiness gate of the national roadmap.
• Plan for graceful degradation when the network is down.[1]

A 36-month roadmap

The goal is not national transformation in 36 months. It is a stable first value loop—a limited, working, evaluated system that earns the right to scale.[1]

Phase	Timeframe	Priority actions	Gate to proceed
Readiness	0–6 months	Legal framework, governance body, data inventory, priority use cases, costing, cybersecurity baseline	Named owner, approved budget, security baseline, baseline metrics
Pilot	6–18 months	Connect selected hospitals/labs, establish MPI, test consent/audit, deploy three use cases	≥90% patient-match accuracy, usable data, security tested, clinician demand
Scale	18–36 months	Expand participation, introduce FHIR APIs, improve incentives	Independent evaluation shows measurable improvement
AI maturity	After foundations	Secure research environment, federated learning, validated AI	External validation, equity assessment, post-deployment monitoring

How to measure success

Do not measure success by the number of connected hospitals alone. Measure whether the system improves care.[1]

Two principles matter:

• Baselines are mandatory. Without a baseline, no post-implementation number is interpretable.
• Beware Goodhart’s Law. When a measure becomes a target, it can be gamed. Pair indicators (e.g., duplicate-test reduction with overall testing volume) and audit them periodically.[1]

Domain	Example indicators	Baseline required?
Data quality	Completeness, accuracy, timeliness, duplicate-record rate, patient-match rate	Yes
Clinical use	Clinician adoption, time saved, reduction in duplicate tests	Yes
Patient experience	Access to records, access-log visibility, complaint resolution, trust surveys	Yes
Safety	Medication errors, missed alerts, security incidents	Yes
Equity	Coverage across regions, income groups, languages, rural areas	Yes
Economic value	Cost per service, avoided duplication, total cost of ownership	Yes
AI performance	External validation, subgroup performance, post-deployment drift	Yes

What to avoid

• Do not buy a platform before defining the problem.
• Do not centralize all data by default.
• Do not treat AI as a substitute for clinical judgment.
• Do not launch models without independent validation.
• Do not ignore small providers, rural facilities, or underrepresented populations.
• Do not promise privacy while collecting data without clear limits.
• Do not measure success only by technical adoption.
• Do not underestimate recurring costs, cybersecurity, and workforce training.
• Do not skip patient identity and record matching.[1]

Final take

The strategic goal is not to build the largest health-data lake. It is to build a system where:

• Clinicians can trust the information in front of them.
• Patients can see and control how their data is used.
• Researchers can generate evidence without weakening privacy.
• Policymakers can detect problems early.
• AI tools are safe, useful, and accountable.[1]

The building blocks already exist—in Korea’s federated analysis, America’s mandated APIs, the UAE’s coordinated execution, Denmark’s longitudinal registers, Estonia’s enforced transparency, Singapore’s operational AI, Taiwan’s insurance-linked cloud, and India’s developing-country architecture. The challenge is sequencing them correctly.[1]

References

1. OECD. Interoperability in Healthcare: Towards an Interconnected Future. OECD Health Working Papers, No. 197. 2026.
2. OECD. Scaling Artificial Intelligence in Health. 2026.
3. OECD. Building People-Centred Digital Health Systems: Lessons from PaRIS. 2026.
4. OECD. Proceeding Report from Madrid Conference on the Responsible Scale of AI in Healthcare. 2026.
5. WHO. Ethics and Governance of Artificial Intelligence for Health: WHO Guidance. 2021.
6. WHO. Ethics and Governance of Artificial Intelligence for Health: WHO Guidance—Executive Summary. 2021.
7. WHO. WHO Issues First Global Report on Artificial Intelligence (AI) in Health and Six Guiding Principles for Its Design and Use. 2021.
8. U.S. ONC. 21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program—Final Rule. 2020.
9. U.S. ONC. Information Blocking Final Rule Webinar. 2025.
10. U.S. ONC. Application Programming Interfaces in Health IT. 2020.
11. U.S. ONC. History. 2026.
12. Lee S, et al. Feasibility Study of Federated Learning on the Distributed Research Network of OMOP Common Data Model. Healthcare Informatics Research. 2023;29(2):168–173.
13. OHDSI. FeederNet: Federated E-Health Big Data for Evidence Renovation Network in Korea. 2022.
14. UAE Government. Digital Health Ecosystem. 2026.
15. UAE MOHAP. About NUMR—Riayati. 2026.
16. Department of Health—Abu Dhabi. Malaffi. 2026.
17. UAE Health Authorities. UAE Health Authorities Announce Successful Integration Between Riayati, Malaffi and NABIDH. 2023.
18. Danish Health Data Authority. Real World Data (RWD) Quality and Experience: Danish National Health Registers.
19. OECD. Personal Health Data Systems in OECD Countries. 2025.
20. OECD. Denmark: Progress in Implementing the European Union Coordinated Plan on Artificial Intelligence, Volume 1. 2025.
21. Danish Health Data Authority. National Health Portals in the Nordics: National Health Portals 2025. 2025.
22. Healthcare Denmark. Collection and Sharing of Health Data.
23. Understanding Patient Data. Case Studies: Denmark. 2025.
24. TEHIK. Health Information System. 2026.
25. TEHIK. Health Portal. 2026.
26. TEHIK. For Foreign Delegations. 2026.
27. TEHIK. Rules for Data Protection. 2026.
28. e-Estonia. e-Health: How Estonia Secures Health Data Integrity.
29. Synapxe. AI Accelerate 2025: Synapxe Boosts AI Capabilities to Transform Healthcare. 2025.
30. Ministry of Health, Singapore. Speech by Mr Tan Kiat How at HIMSS26 APAC Health Conference and Exhibition. 2026.
31. Taiwan NHIA. NHI MediCloud System. 2022.
32. Taiwan NHIA. NHI MediCloud System Safeguards Everyone Through Digital Technology. 2022.
33. Taiwan NHIA. NHI Utilizes Digital Technologies and Works With Medical Care Institutions Towards Smart Health Care to Protect the Health of the Public. 2021.
34. Taiwan NHIA. Taiwan Can Help—NHI’s Contribution in COVID-19. 2022.
35. Taiwan NHIA. Using NHI Cloud Technologies to Tackle the Pandemic. 2022.
36. Taiwan NHIA. NHI Partners With Hospitals to Accelerate the Digital Transformation. 2025.
37. European Union. Regulation (EU) 2025/327 on the European Health Data Space. 2025.
38. European Commission. European Health Data Space.
39. Iacobucci G. NHS England cancels care.data programme. BMJ. 2016;353:i3680.
40. UK National Audit Office. The National Programme for IT in the NHS: An Update on the Delivery of Detailed Care Records Systems. 2011.
41. UK National Audit Office. Investigation: WannaCry Cyber Attack and the NHS. 2018.
42. The Ayushman Bharat Digital Mission of India: An Assessment. Health Systems & Reform. 2024.
43. Integrated Health Record Viewers and Reduction in Duplicate Medical Imaging: Retrospective Observational Analysis. JMIR Medical Informatics. 2022;10(5):e32168.
44. European Union. Regulation (EU) 2024/1689 (Artificial Intelligence Act). 2024.
45. Federated Learning in Smart Healthcare: A Comprehensive Review on Privacy, Security, and Predictive Analytics with IoT Integration. Healthcare (Basel). 2024;12(24):2587.[1]

Author: Seyed Alireza Alhosseini Almodarresieh
My site :https://almodarresieh.github.io/